Intrinsiqq
YD Bio Limited logo

YD Bio Limited Quality Score

YDES

Compare
Quality25

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-40.3x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-40.1x

Negative FCF, no valuation support

Revenue Growth
100/100
30.6%

Above 10% CAGR, strong compounder

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Margin Trend
0/100
-880.7pp

Contracted >2pp, margin pressure

Capital Structure
100/100
-$6M

Net cash position, no leverage concern

2023
$87098
$47576
2024
$3.00M
$22265
2025
$6.00M
$6764
CashDebt
Return on Capital
0/100
-125.8%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

YD Bio (YDES) quality: score, margins and returns

YD Bio (YDES) scores 25/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 5 metrics each scored 0 to 100, on -882.7% operating margins and -125.8% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is YD Bio (YDES) a high-quality business?+

YD Bio scores 25 out of 100 on Intrinsiqq's quality score, a weighted blend of 5 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -882.7% operating margin and a -125.8% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does YD Bio's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from YDES's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where YD Bio scores well and where it falls behind.

What is YD Bio's return on invested capital (ROIC)?+

YD Bio earns about -125.8% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to YDES's margins and growth on this scorecard to judge durability.

How profitable is YD Bio?+

YD Bio runs an operating margin of about -882.7% and a net margin of about -1,392.6%. Revenue has grown at roughly 30.6% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Biotechnology · Pick stocks to compare with YDES

CompareIntrinsic value
PROGEN.XSTOProstatype Genomics AB
€0.01+3.45%10
OXUR.XBRUOxurion NV
€0.00+0.00%15
ITOCPheton Holdings Ltd.
$1.59+6.00%18
ATORX.XSTOAlligator Bioscience AB
kr 0.01-5.68%10
TNG.XPARTransgene SA
€0.69+0.43%10
NANECH.XSTONanoEcho AB
No recent price10
BIBB.XSTOBibbinstruments AB
€0.03+7.69%10
TANAFTian'an Technology Group Ltd.
$0.10+0.00%61

Held by ETFs

YDES is in 1 US ETF. The largest of them, with YDES's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing YDES

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.